Inflammatory markers: linking unstable plaques to coronary event, an interventional perspective

References

• Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000; 101: 598–603.
   PubMed Web of Science ®Google Scholar
• Schoenhagen P, Tuzcu EM, Ellis SG. Plaque vulnerability, plaque rapture, and acute coronary syndromes: (multifocal manifestation of a systemic disease process. Circulation 2002; 106: 760–2.
   Google Scholar
• Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 2003; 107: 2068–71.
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. ArteriosclerThromb Vase Biol 2000; 20: 1262–75.
   PubMed Web of Science ®Google Scholar
• Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664–72.
   PubMed Web of Science ®Google Scholar
• van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rapture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36–44.
   PubMed Web of Science ®Google Scholar
• Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation 2001; 103: 1718–20.
   PubMed Web of Science ®Google Scholar
• Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844–50.
   PubMed Web of Science ®Google Scholar
• Kolodgie FD, Burke AP, Farb A et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001; 16: 285–92.
   PubMed Web of Science ®Google Scholar
• Farb A, Burke AP, Tang AL et al. Coronary plaque erosion without rapture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1354–63.
   PubMed Web of Science ®Google Scholar
• Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996; 94: 2013–20.
   PubMed Web of Science ®Google Scholar
• Asakura M, Ueda Y, Yamaguchi O et al. Extensive devel opment of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 2001; 37: 1284–8.
   PubMed Web of Science ®Google Scholar
• Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915–22.
   PubMed Web of Science ®Google Scholar
• Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276–82.
   PubMed Web of Science ®Google Scholar
• Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657–71.
   PubMed Web of Science ®Google Scholar
• Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347: 5–12.
   PubMed Web of Science ®Google Scholar
• Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002; 106: 804–8.
   PubMed Web of Science ®Google Scholar
• Stefanadis C, Toutouzas K, Tsiamis E et al. Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 2001; 37: 1277–83.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149–53.
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417–24.
   PubMed Web of Science ®Google Scholar
• Casscells W, Naghavi M, Willerson FT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003; 107: 2072–5.
   PubMed Web of Science ®Google Scholar
• Monroe VS, Kerensky RA, Rivera E, Smith KM, Pepine CJ. Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes. J Am Coll Cardiol 2003; 41: 23S-30S.
   Google Scholar
• Horie T, Sekiguchi M, Hirosawa K. Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section. Br Heart J 1978; 40: 153–61.
   PubMedGoogle Scholar
• Qiao JH, Fishbein MC. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. J Am Coll Cardiol 1991; 17: 1138–42.
   PubMed Web of Science ®Google Scholar
• Hangartner JR, Charleston AJ, Davies MJ, Thomas AC. Morphological characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J 1986; 56: 501–8.
   PubMedGoogle Scholar
• Virmani R, Guagliumi G, Farb A et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109: 701–5.
   Google Scholar
• Kereiakes DJ. The Emperor's clothes: in search of the vulnerable plaque. Circulation 2003; 107: 2076–7.
   Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868–74.
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A, Conover CA, Overgaard MT et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022–9.
   PubMed Web of Science ®Google Scholar
• Mallat Z, Corbaz A, Scoazec A et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001; 104: 1598–603.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004; 109: FV6-19.
   Google Scholar
• Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation: Part I. Circulation 2003; 108: 1917–23.
   PubMed Web of Science ®Google Scholar
• Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, Verma S. Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation 2003; 108: 2041–8.
   PubMed Web of Science ®Google Scholar
• Jabs WJ, Theissing E, Nitschke M et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003; 108: 1428–31.
   PubMed Web of Science ®Google Scholar
• Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108: 1930–2.
   PubMed Web of Science ®Google Scholar
• Verma S, Szmitko PE, Yeh ET. C-reactive protein: structure affects function. Circulation 2004; 109: 1914–7.
   PubMed Web of Science ®Google Scholar
• Festa A, D'Agostino R, Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42–7.
   PubMed Web of Science ®Google Scholar
• Aronson D, Bartha P, Zinder O et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord 2004; 28: 674–9.
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785–8.
   PubMed Web of Science ®Google Scholar
• Kerner A, Avizohar O, Sella R et al. Association between Elevated Liver Enzymes and C-Reactive Protein: Possible Hepatic Contribution to Systemic Inflammation in the Metabolic Syndrome. Arterioscler Thromb Vase Biol (in press).
   Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796–808.
   PubMed Web of Science ®Google Scholar
• Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621–36.
   PubMed Web of Science ®Google Scholar
• Mackiewicz A, Speroff T, Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991; 146: 3032–7.
   PubMed Web of Science ®Google Scholar
• Aronson D, Bartha P, Zinder O et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med 2004; 21: 39–44.
   PubMedGoogle Scholar
• Tracy RP, Psaty BM, Macy E et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vase Biol 1997; 17: 2167–76.
   PubMed Web of Science ®Google Scholar
• Aronson D, Sheikh-Ahmad M, Avizohar O et al. CReactive protein is inversely related to physical fitness in middle-aged subjects. Atherosclerosis 2004; 176: 173–9.
   PubMed Web of Science ®Google Scholar
• Aronson D, Sella R, Sheikh-Ahmad M et al. The asso elation between cardiorespiratory citness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol (in press).
   Google Scholar
• Sano T, Tanaka A, Namba M et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 2003; 108: 282–5.
   PubMed Web of Science ®Google Scholar
• Schwartz RS, Bayes-Genis A, Lesser JR, Sangiorgi M, Henry TD, Conover CA. Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers. J Interv Cardiol 2003; 16: 231–42.
   PubMedGoogle Scholar
• Blankenberg S, Rupprecht HJ, Bickel C et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003; 349: 1605–13.
   PubMed Web of Science ®Google Scholar
• Brennan ML, Penn MS,Lente FVan et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003; 349: 1595–604.
   PubMed Web of Science ®Google Scholar
• Biasucci LM, Vitelli A, Liuzzo G et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996; 94: 874–7.
   PubMed Web of Science ®Google Scholar
• Ferreiros ER, Boissonnet CP, Pizarro R et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999; 100: 1958–63.
   PubMed Web of Science ®Google Scholar
• Zebrack JS, Muhlestein JB, Home BD, Anderson JL. Creactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002; 39: 632–7.
   PubMed Web of Science ®Google Scholar
• Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002; 39: 1917–23.
   PubMed Web of Science ®Google Scholar
• Suleiman M, Aronson D, Reisner SA et al. Admission Creactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003; 115: 695–701.
   PubMedGoogle Scholar
• Zebrack JS, Anderson JL. Should C-reactive protein be measured routinely during acute myocardial infarction? Am J Med 2003; 115: 735–7.
   Google Scholar
• Jaffe AS, Katus H. Acute coronary syndrome biomarkers: the need for more adequate reporting. Circulation 2004; 110: 104–6.
   PubMed Web of Science ®Google Scholar
• Azar RR, McKay RG, Kiernan FJ et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 1997; 80: 1476–8.
   Google Scholar
• Gaspardone A, Crea F, Versaci F et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998; 82: 515–8.
   PubMed Web of Science ®Google Scholar
• Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000; 85: 92-5: A8.
   Google Scholar
• Lincoff AM, Kereiakes DJ, Mascelli MA et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001; 104: 163–7.
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Buffon A, Biasucci LM et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98: 2370–6.
   PubMed Web of Science ®Google Scholar
• Gottsauner-Wolf M, Zasmeta G, Hornykewycz S et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21: 1152–8.
   PubMed Web of Science ®Google Scholar
• Lee WL, Sheu WH, Liu TJ et al. The short-/intermediateterm changes in novel vascular inflammatory markers after angioplasty plus stenting in patients with symptomatic advanced systemic arterial diseases. Atherosclerosis 2004; 176: 125–32.
   Google Scholar
• Farb A, Sangiorgi G, Carter AJ et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44–52.
   PubMed Web of Science ®Google Scholar
• Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation 1998; 98: 224–33.
   PubMed Web of Science ®Google Scholar
• Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224–30.
   PubMed Web of Science ®Google Scholar
• Rogers C, Welt FG, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vase Biol 1996; 16: 1312–8.
   PubMed Web of Science ®Google Scholar
• Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol 2000; 86: 6H–11H.
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Mintz GS, Dussaillant GR et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996; 94: 1247–54.
   PubMed Web of Science ®Google Scholar
• Goldberg A, Zinder O, Zdorovyak A et al. Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina. Am Heart J 2003; 146: 819–23.
   Google Scholar
• Biffl WL, Moore EE, Moore FA, Peterson VM. Interleukin- 6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996; 224: 647–64.
   Google Scholar
• Laskey WK, Gellman J. Inflammatory markers increase following exposure to radiographic contrast media. Acta Radiol 2003; 44: 498–503.
   PubMed Web of Science ®Google Scholar
• Dehmer GJ, Nichols TC, Li S, Koch GG, Tate DA, Griggs TR. Effects of an ionic and nonionic contrast agent on von Willebrand factor assessed during coronary angiography. Am J Cardiol 1999; 84: 223-5: A8.
   Google Scholar
• Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365–72.
   PubMed Web of Science ®Google Scholar
• Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101: 570–80.
   PubMed Web of Science ®Google Scholar
• Buffon A, Liuzzo G, Biasucci LM et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34: 1512–21.
   PubMed Web of Science ®Google Scholar
• Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schachinger V, Zeiher AM. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001; 37: 839–46.
   PubMed Web of Science ®Google Scholar
• Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 Antiplatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 2000; 35: 1535–42.
   PubMed Web of Science ®Google Scholar
• Zairis MN, Ambrose JA, Manousakis SJ et al. The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study. J Am Coll Cardiol 2002; 40: 1375–82.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Imamura T, Hatakeyama K et al. Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation. Am J Cardiol 2004; 93: 611–4.
   Google Scholar
• Versaci F, Gaspardone A, Tomai F et al. Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol 2002; 40: 1935–42.
   PubMed Web of Science ®Google Scholar
• de Winter RJ, Koch KT, van Straalen JP et al. C-reactive protein and coronary events following percutaneous coronary angioplasty. Am J Med 2003; 115: 85–90.
   PubMed Web of Science ®Google Scholar
• Dibra A, Mehilli J, Braun S et al. Association between Creactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 2003; 114: 715–22.
   PubMed Web of Science ®Google Scholar
• Rittersma SZ, de Winter RJ, Koch KT et al. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement. Clin Chem 2004; 50: 1589–96.
   Google Scholar
• Biasucci LM, Biondi-Zoccai GG. Preprocedural C-reactive protein for risk prediction before percutaneous coronary intervention (PCI): a European perspective. Clin Chem 2004; 50: 1492–4.
   Google Scholar
• Morrow DA. Preprocedural C-reactive protein for risk prediction before percutaneous coronary intervention (PCI): a US perspective. Clin Chem 2004; 50: 1489–91.
   Google Scholar
• Chew DP, Bhatt DL, Robbins MA et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001; 104: 992–7.
   PubMed Web of Science ®Google Scholar
• Chan AW, Bhatt DL, Chew DP et al. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation 2003; 107: 1750–6.
   PubMed Web of Science ®Google Scholar
• Saleh N, Svane B, Velander M, Nilsson T, Hansson LO, Tornvall P. C-reactive protein and myocardial infarction during percutaneous coronary intervention. J Intern Med 2004; 255: 33–9.
   Google Scholar
• Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 1997; 96: 4204–10.
   PubMed Web of Science ®Google Scholar
• Morrow DA, Rifai N, Amman EM et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syn- dromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998; 31: 1460–5.
   Google Scholar
• Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–72.
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Tiret L, Bickel C et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24–30.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88–92.
   PubMed Web of Science ®Google Scholar
• Schonbeck U, Varo N, Libby P, Buring J, Ridker PM. Soluble CD40L and cardiovascular risk in women. Circulation 2001; 104: 2266–8.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491–5.
   PubMed Web of Science ®Google Scholar
• Brown DA, Breit SN, Buring J et al. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 2002; 359: 2159–63.
   Google Scholar
• Packard CJ, O'Reilly DS, Caslake MJ et al. Lipoproteinassociated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 2000; 343: 1148- 55.
   Google Scholar
• Koenig W, Khuseyinova N, Lowel H, Trischler G, Meisinger C. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by Creactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany. Circulation 2004; 110: 1903–8.
   PubMed Web of Science ®Google Scholar
• Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001; 141: 211–7.
   PubMed Web of Science ®Google Scholar
• Molloy KJ, Thompson MM, Jones JL et al. Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity. Circulation 2004; 110: 337–43.
   PubMedGoogle Scholar